- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Breaking Down Taletrectinib’s FDA Approval: Jorge J. Nieva, MDIn this interview with TRUST-I and TRUST-II trial investigator, Jorge J. Nieva, MD, USC Keck School of Medicine, he walks through the design of the trials, the results that supported the FDA approval, and taletrectinib’s potential to redefine first-line therapy.
Latest:
Geographic Variation in Medicare Home Health ExpendituresThis study attempts to identify the sources of the significant 2.5-fold variation found in home health expenditures, a possible indicator of inefficiency and waste.
Latest:
Challenges Faced by Medicaid Managed Care Coordinators Working With Members With Substance Use DisorderAccessing medical and social resources for patients, heavy administrative burden, and lack of data integration are barriers to Medicaid managed care organization care coordinators’ job performance.
Latest:
Supporting Patients and Primary Care ProvidersPanelists discuss how supporting primary care providers requires moving beyond passive quality measures to peer-to-peer education, transparent performance feedback, multidisciplinary team resources, and creative care delivery models that address the "27-hour day" problem.
Latest:
Treosulfan Approval Offers Novel Option for Allo-HSCT Conditioning in AML/MDSMikkael A. Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly approved agent for allogeneic hematopoietic stem cell transplantation (allo-HSCT) conditioning in acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Latest:
Advancing Team-Based Primary Care: The Importance and Challenges in 2023This editorial describes several key lessons about the development of effective value-based care delivery.
Latest:
KAP Regarding ChatGPT Among Health Care Professionals: CorrespondenceThis letter discusses previously published research that paves the way for deeper exploration of the ethical and human aspects of artificial intelligence in health care.
Latest:
Health Care Leader Perspectives on State Government–Sponsored Accountable Care for Public EmployeesQualitative interviews reveal health care leader perspectives on how state governments influenced payment reform by developing an accountable care program for public employees.
Latest:
Impact of COVID-19 Pandemic on Accessibility of Taiwanese Medical CareThe COVID-19 pandemic disrupted access to routine medical care in community populations in Taiwan. The unmet needs should be emphasized as normal life resumes.
Latest:
Care Coordination in Primary Care: Mapping the TerritoryA survey completed by 100% of leaders of diverse care systems in Minnesota participating in an observational study showed little difference in approach to care coordination.
Latest:
Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney DiseasePatients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.
Latest:
Variation in Network Adequacy Standards in Medicaid Managed CareMedicaid managed care network adequacy standards exhibit significant heterogeneity across regions and specialties, potentially creating large variations in health care access and quality.
Latest:
Tacking Upwind: Reducing Spending Among High-risk Commercially Insured PatientsAlthough commercial accountable care organization populations are healthy on average, some individuals might benefit from programs for high-risk patients to mitigate high levels of health care utilization.
Latest:
Female Patients With ILD Show Lower ICU Mortality Rates: Matthew Viggiano, MDMatthew Viggiano, MD, internal medicine resident, Temple University Hospital, shares findings on a study in which female patients with interstitial lung disease (ILD) admitted to the intensive care unit (ICU) experienced significantly lower mortality rates and shorter hospital stays than male patients with ILD.
Latest:
The Future of BTK Inhibitor Therapies in CLL and MCLPanelists discuss the future of Bruton tyrosine kinase (BTK) inhibitor therapies, considering emerging treatments, regulatory changes, evolving cost dynamics, and the current unmet needs in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) care, and how these factors may shape the landscape of treatment options.
Latest:
Inadequate Insurance Coverage for Overweight/Obesity ManagementThis article reviews the obesity epidemic in America and discusses inadequate insurance coverage.
Latest:
Combined Effect of Continuous Glucose Monitoring and Semaglutide: Analysis of Administrative ClaimsClaims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone.
Latest:
Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular DystrophyAltruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 per year.
Latest:
The Unintended Consequences of Medicare’s Wage Index Adjustment on Device-Intensive Hospital ProceduresThe authors found an association between Medicare’s wage index adjustment and the differential use of labor-intensive surgical procedures and medical device–intensive minimally invasive clinical procedures across the United States.
Latest:
Association Between Hospital-Insurer Contract Structure and Hospital PerformanceHospital performance measures, such as prices and costs, are associated with hospital-insurer contract types.
Latest:
Growth of Electronic Consultations in the Veterans Health AdministrationThis study evaluates the growth in electronic consultation use over the first 7 years after its implementation across the entire Veterans Health Administration system.
Latest:
Increasing Trust in Health CareThis commentary describes 4 dimensions of trust that have been illuminated by contributions from leading health care organizations to the ABIM Foundation’s Trust Practices Network.
Latest:
More Data Needed on Tissue-Agnostic Therapy Use in Breast CancerThis new study concluded that the breast cancer space needs more data to evaluate if there is a place for tissue-agnostic treatments for these patients.
Latest:
Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into ActionNo One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.
Latest:
Contributor: 6 Myths to Avoid About Patient Engagement SolutionsPatient engagement solutions facilitate active care participation, but several myths persist that hinder their adoption and implementation.
Latest:
Contributor: Data, Education, and Community: The Winning Formula for Addressing SDOH for Kidney Care PatientsAddressing patients with chronic kidney disease requires a commitment to data, education, and community, specifically in those affected by social determinants of health (SDOH).
Latest:
Noninvasive Ventilation at Home Reduces Mortality in COPD With CRFThis study explores the association between receiving noninvasive ventilation at home and mortality, hospitalizations, and emergency department visits in patients with chronic obstructive pulmonary disease (COPD) with chronic respiratory failure (CRF).
